We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+3.36%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$24.6B
AUM Growth
-$4.32B
(-15%)
Cap. Flow
-$4.58B
Cap. Flow
% of AUM
-18.6%
Top 10 Holdings %
Top 10 Hldgs %
35.76%
Holding
1,158
New
25
Increased
204
Reduced
826
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$417M |
| 2 |
Tesla
TSLA
|
+$152M |
| 3 |
Broadcom
AVGO
|
+$74.2M |
| 4 |
Qualcomm
QCOM
|
+$39.4M |
| 5 |
Marvell Technology
MRVL
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$341M |
| 3 |
Applied Materials
AMAT
|
+$243M |
| 4 |
Lam Research
LRCX
|
+$194M |
| 5 |
NVIDIA
NVDA
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.84% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Healthcare | 3.78% |
| 5 | Industrials | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Atlantic Union Bankshares
AUB
$6.06B
| $4.68M | 0.02% |
131,000
-18,370
| -12% | -$692K |
|
402
PTC Therapeutics
PTCT
$6.5B
| $4.68M | 0.02% |
68,685
-9,822
| -13% | -$696K |
|
403
BOK Financial
BOKF
$8.6B
| $4.66M | 0.02% |
36,375
+5
| +0% | +$642 |
|
404
Norfolk Southern
NSC
$74.3B
| $4.64M | 0.02% |
16,179
-5,605
| -26% | -$1.67M |
|
405
Brown & Brown
BRO
$22.2B
| $4.64M | 0.02% |
71,174
-18,403
| -21% | -$1.33M |
|
406
Glacier Bancorp
GBCI
$6.66B
| $4.63M | 0.02% |
103,705
-33,920
| -25% | -$1.61M |
|
407
Royal Caribbean
RCL
$76.7B
| $4.63M | 0.02% |
16,819
-6,948
| -29% | -$2.07M |
|
|
NUVL
408
DELISTED
Nuvalent
NUVL
| $4.62M | 0.02% |
45,083
-862
| -2% | -$87.8K |
|
409
Kymera Therapeutics
KYMR
$9.08B
| $4.61M | 0.02% |
55,331
-3,322
| -6% | -$263K |
|
410
CG Oncology
CGON
$6.11B
| $4.6M | 0.02% |
67,979
-38,073
| -36% | -$2.16M |
|
411
Natera
NTRA
$37.8B
| $4.59M | 0.02% |
22,942
-2,010
| -8% | -$433K |
|
412
Bankunited
BKU
$3.34B
| $4.59M | 0.02% |
101,569
-31,978
| -24% | -$1.49M |
|
413
Twist Bioscience
TWST
$5.87B
| $4.57M | 0.02% |
96,255
-18,003
| -16% | -$807K |
|
414
Krystal Biotech
KRYS
$9.93B
| $4.57M | 0.02% |
17,687
-6,581
| -27% | -$1.75M |
|
415
KeyCorp
KEY
$24.9B
| $4.57M | 0.02% |
227,812
-75,354
| -25% | -$1.58M |
|
416
Vaxcyte
PCVX
$8.09B
| $4.56M | 0.02% |
78,402
-55,362
| -41% | -$3.01M |
|
417
M/I Homes
MHO
$3.81B
| $4.55M | 0.02% |
37,182
-5,617
| -13% | -$756K |
|
418
Mirum Pharmaceuticals
MIRM
$6.98B
| $4.54M | 0.02% |
49,160
-23,783
| -33% | -$2.24M |
|
|
FOLD
419
DELISTED
Amicus Therapeutics
FOLD
| $4.54M | 0.02% |
313,882
-179,206
| -36% | -$2.57M |
|
420
Travere Therapeutics
TVTX
$5.23B
| $4.53M | 0.02% |
152,433
-16,775
| -10% | -$501K |
|
|
ACLX
421
DELISTED
Arcellx
ACLX
| $4.53M | 0.02% |
39,441
-30,074
| -43% | -$2.65M |
|
422
Ionis Pharmaceuticals
IONS
$8.93B
| $4.53M | 0.02% |
60,308
-13,675
| -18% | -$1.08M |
|
423
Halozyme
HALO
$9.23B
| $4.49M | 0.02% |
69,505
-25,327
| -27% | -$1.79M |
|
424
Banc of California
BANC
$3.29B
| $4.48M | 0.02% |
254,577
-56,169
| -18% | -$1.07M |
|
425
Celcuity
CELC
$4.4B
| $4.45M | 0.02% |
38,963
-18,165
| -32% | -$1.98M |
|
Similar funds
CS
AF
SC
RG
JG
Rafferty Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Rafferty Asset Management held 1,158 positions worth $24.6B, down 15% from $28.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Rafferty Asset Management withdrew a net $4.58B in Q1 2026, closing 101 positions and reducing 826 holdings. Its most notable exit was AstraZeneca, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Rafferty Asset Management opened a new position in FTAI Aviation worth $6.39M.
- Rafferty Asset Management's largest Q1 2026 buy was FTAI Aviation: 26,098 shares worth $6.39M.
- Rafferty Asset Management added most to iShares MSCI South Korea ETF in Q1 2026, an estimated $417M increase.
- Rafferty Asset Management's biggest Q1 2026 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $647M.
- Rafferty Asset Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.3M.
- Rafferty Asset Management's ten largest holdings make up 36% of its $24.6B portfolio in Q1 2026.
- Rafferty Asset Management opened 25 new positions and closed 101 in Q1 2026.
- Rafferty Asset Management's portfolio value fell 15% quarter-over-quarter to $24.6B.
Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.